1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Zakova, L.
Veverka, V.
Jiracek, J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C6 H10 N3 O2 1
156.162
D-HISTIDINE
D-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
288
10230
10240
10.1074/jbc.M112.448050
23447530
Structural integrity of the B24 site in human insulin is important for hormone functionality.
2013
2383.698
Insulin A chain
1
syn
polymer
3424.926
Insulin B chain
F24(D-HIS)
1
syn
polymer
no
no
GIVEQCCTSICSLYQLENYCN
GIVEQCCTSICSLYQLENYCN
A
polypeptide(L)
no
yes
FVNQHLCGSHLVEALYLVCGERG(DHI)FYTPKT
FVNQHLCGSHLVEALYLVCGERGHFYTPKT
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
repository
Initial release
Database references
1
0
2013-03-06
1
1
2013-06-05
BMRB
Y
RCSB
2012-12-29
REL
REL
REL
9606
human
Homo sapiens
sample
9606
human
Homo sapiens
sample
structures with the least restraint violations
100
30
2D 1H-1H TOCSY
2D 1H-1H NOESY
2D DQF-COSY
0.250
mM
0.250
mM
25
mM
[U-2H]
0.025
8.0
ambient
298
K
simulated annealing
1
closest to the average
0.250 mM chain_A, 0.250 mM chain_B, 25 mM [U-2H] TRIS, 95% H2O/5% D2O
CASE, DARDEN, CHEATHAM, III, SIMMERLING, WANG, DUKE, LUO, KOLLMAN
refinement
AMBER
600
Bruker
Avance
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
CYS
6
n
6
CYS
6
A
CYS
7
n
7
CYS
7
A
THR
8
n
8
THR
8
A
SER
9
n
9
SER
9
A
ILE
10
n
10
ILE
10
A
CYS
11
n
11
CYS
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
TYR
14
n
14
TYR
14
A
GLN
15
n
15
GLN
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
ASN
18
n
18
ASN
18
A
TYR
19
n
19
TYR
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
PHE
1
n
1
PHE
1
B
VAL
2
n
2
VAL
2
B
ASN
3
n
3
ASN
3
B
GLN
4
n
4
GLN
4
B
HIS
5
n
5
HIS
5
B
LEU
6
n
6
LEU
6
B
CYS
7
n
7
CYS
7
B
GLY
8
n
8
GLY
8
B
SER
9
n
9
SER
9
B
HIS
10
n
10
HIS
10
B
LEU
11
n
11
LEU
11
B
VAL
12
n
12
VAL
12
B
GLU
13
n
13
GLU
13
B
ALA
14
n
14
ALA
14
B
LEU
15
n
15
LEU
15
B
TYR
16
n
16
TYR
16
B
LEU
17
n
17
LEU
17
B
VAL
18
n
18
VAL
18
B
CYS
19
n
19
CYS
19
B
GLY
20
n
20
GLY
20
B
GLU
21
n
21
GLU
21
B
ARG
22
n
22
ARG
22
B
GLY
23
n
23
GLY
23
B
DHI
24
n
24
DHI
24
B
PHE
25
n
25
PHE
25
B
TYR
26
n
26
TYR
26
B
THR
27
n
27
THR
27
B
PRO
28
n
28
PRO
28
B
LYS
29
n
29
LYS
29
B
THR
30
n
30
THR
30
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
10
B
B
DHI
PHE
24
25
144.91
19
B
B
HIS
LEU
5
6
-149.68
27
A
A
THR
SER
8
9
-148.37
29
B
B
ARG
GLY
22
23
147.98
30
B
B
ARG
GLY
22
23
147.36
1
A
TYR
19
0.103
SIDE CHAIN
3
7.43
1.20
111.50
118.93
A
A
A
CB
CA
C
CYS
CYS
CYS
6
6
6
N
4
3.29
0.50
120.30
123.59
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
22
22
22
N
16
4.36
0.50
120.30
124.66
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
22
22
22
N
1
A
GLN
5
57.60
-12.45
1
A
CYS
6
56.49
-108.40
1
A
CYS
7
55.14
18.26
1
A
THR
8
-90.90
-61.70
1
B
VAL
2
-133.76
-45.17
1
B
CYS
7
64.13
138.41
1
B
SER
9
-122.68
-168.05
1
B
HIS
10
61.43
-28.64
1
B
DHI
24
145.77
-53.50
1
B
PHE
25
52.05
-161.90
2
A
CYS
7
52.80
-70.92
3
A
CYS
6
-80.40
45.11
3
A
THR
8
65.31
-50.20
3
B
HIS
5
65.74
162.15
4
A
CYS
7
65.72
153.85
4
B
GLN
4
64.04
156.10
4
B
SER
9
61.48
-25.49
4
B
DHI
24
79.26
-40.87
4
B
TYR
26
54.48
103.79
5
A
GLN
5
-78.13
44.48
5
A
ILE
10
47.37
94.16
5
B
VAL
2
54.62
-54.85
5
B
LEU
6
-79.46
46.94
5
B
TYR
26
55.22
98.72
6
A
GLN
5
-142.15
54.43
6
A
CYS
6
55.63
19.70
6
B
ASN
3
55.39
-146.64
6
B
CYS
7
-147.05
-98.35
6
B
HIS
10
60.37
-27.92
6
B
GLU
21
58.79
171.72
7
B
GLN
4
61.14
174.30
8
B
ARG
22
-89.82
33.27
9
A
CYS
7
56.03
148.24
9
A
SER
9
-103.58
-149.69
9
A
SER
12
59.64
167.82
9
B
DHI
24
-60.67
-142.35
11
A
VAL
3
67.29
-25.02
11
A
GLN
5
59.53
-52.95
11
A
CYS
7
-167.50
-40.54
11
A
LEU
13
62.92
-42.37
12
A
THR
8
64.22
-35.65
12
B
GLN
4
-69.74
-179.63
12
B
CYS
7
-22.74
-45.73
13
A
CYS
6
-86.65
42.20
13
A
THR
8
60.45
-47.08
13
B
VAL
2
64.06
-47.68
13
B
CYS
19
-141.74
-32.26
13
B
LYS
29
64.99
136.98
14
A
CYS
11
61.25
146.74
14
B
VAL
2
55.34
-19.96
14
B
SER
9
-151.02
13.71
15
A
VAL
3
55.58
16.82
15
A
SER
12
-78.95
37.22
15
A
LEU
13
64.13
-50.56
15
B
HIS
10
64.56
-32.63
15
B
THR
27
58.00
78.51
16
A
GLN
5
61.94
-17.24
16
B
ASN
3
-83.25
42.33
16
B
SER
9
64.32
-1.98
16
B
PHE
25
50.94
-142.32
17
A
GLU
4
-80.41
44.91
17
A
GLN
5
-129.60
-81.18
17
B
PHE
25
-145.56
-45.15
18
A
ILE
2
42.98
-149.37
18
A
CYS
7
-136.22
-36.14
18
B
LEU
6
-107.60
-62.05
18
B
CYS
7
62.26
-129.31
18
B
HIS
10
62.34
-34.16
18
B
TYR
26
-139.54
-63.05
18
B
THR
27
50.30
125.57
19
A
CYS
6
-69.26
95.31
19
B
HIS
5
-149.50
19.46
19
B
LEU
6
46.77
-133.10
19
B
CYS
7
55.12
-177.12
19
B
THR
27
-115.64
78.33
20
B
VAL
2
-148.67
-26.12
20
B
HIS
10
63.42
-28.87
20
B
CYS
19
-91.67
53.61
20
B
PHE
25
63.06
-41.03
20
B
TYR
26
64.55
-50.14
20
B
LYS
29
60.18
175.17
21
A
ILE
2
60.75
169.34
21
A
CYS
20
-145.96
-40.94
21
B
VAL
2
53.61
-44.18
21
B
DHI
24
-57.55
150.34
21
B
PHE
25
51.23
-105.00
21
B
TYR
26
62.59
-50.00
22
A
THR
8
54.15
17.91
22
B
LEU
6
59.39
-34.90
22
B
CYS
19
-128.83
-165.88
23
A
GLN
5
49.39
26.72
23
A
THR
8
55.51
-34.84
23
B
PHE
25
57.95
153.65
24
B
VAL
2
52.33
-7.43
24
B
GLN
4
-78.96
-152.57
24
B
DHI
24
154.21
-11.18
24
B
PHE
25
64.38
154.94
25
A
VAL
3
-137.28
-30.90
25
A
CYS
6
56.50
-80.72
25
A
CYS
7
37.51
-76.30
25
B
VAL
2
-136.87
-45.12
25
B
PHE
25
62.83
-50.88
25
B
TYR
26
47.97
82.40
25
B
THR
27
-116.30
78.82
26
A
VAL
3
-153.22
35.82
26
A
GLN
5
68.05
149.19
26
A
CYS
7
44.38
-88.67
26
B
ASN
3
-152.01
50.18
26
B
CYS
7
-88.56
-151.76
26
B
SER
9
59.35
162.94
26
B
HIS
10
63.02
-38.01
26
B
VAL
18
-126.36
-55.65
26
B
GLU
21
-130.03
-108.63
27
A
CYS
6
-79.96
41.01
27
A
SER
9
56.58
153.77
27
A
CYS
11
62.01
160.43
27
B
SER
9
61.83
-39.89
27
B
THR
27
60.46
69.78
28
A
GLN
5
57.94
176.36
28
A
THR
8
56.23
-43.83
28
B
LEU
6
-107.53
78.37
28
B
HIS
10
60.20
-22.50
29
A
CYS
6
-28.82
110.86
29
A
THR
8
57.02
-42.46
29
B
VAL
2
64.90
-35.39
29
B
GLU
21
-146.28
49.16
29
B
ARG
22
61.81
-16.43
30
A
CYS
6
-59.04
-73.18
30
A
CYS
7
40.59
-91.31
30
B
CYS
19
-97.59
30.21
30
B
GLU
21
-135.10
-35.23
30
B
ARG
22
-163.10
-47.08
30
B
THR
27
26.31
66.24
Insulin A chain, Insulin B chain
closest to the average, model1
Structure of [D-HisB24] insulin analogue at pH 8.0
1
N
N
2
N
N
A
SER
12
A
SER
12
HELX_P
A
ASN
21
A
ASN
21
1
1
10
B
HIS
10
B
HIS
10
HELX_P
B
CYS
19
B
CYS
19
1
2
10
disulf
2.036
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
11
A
SG
CYS
11
1_555
disulf
2.035
A
CYS
7
A
SG
CYS
7
1_555
B
CYS
7
B
SG
CYS
7
1_555
disulf
2.033
A
CYS
20
A
SG
CYS
20
1_555
B
CYS
19
B
SG
CYS
19
1_555
covale
1.337
B
GLY
23
B
C
GLY
23
1_555
B
DHI
24
B
N
DHI
24
1_555
covale
1.343
B
DHI
24
B
C
DHI
24
1_555
B
PHE
25
B
N
PHE
25
1_555
HORMONE
insulin, HORMONE
B
GLN
4
B
GLN
4
1
B
HIS
5
B
HIS
5
-13.30
B
CYS
7
B
CYS
7
1
B
GLY
8
B
GLY
8
-6.73
A
GLN
5
A
GLN
5
2
A
CYS
6
A
CYS
6
-9.48
B
PHE
1
B
PHE
1
2
B
VAL
2
B
VAL
2
-0.15
B
PRO
28
B
PRO
28
2
B
LYS
29
B
LYS
29
0.01
A
CYS
7
A
CYS
7
4
A
THR
8
A
THR
8
-9.73
A
THR
8
A
THR
8
4
A
SER
9
A
SER
9
-1.01
A
THR
8
A
THR
8
5
A
SER
9
A
SER
9
-1.48
A
GLY
1
A
GLY
1
6
A
ILE
2
A
ILE
2
1.50
B
PHE
1
B
PHE
1
6
B
VAL
2
B
VAL
2
-6.20
B
GLN
4
B
GLN
4
6
B
HIS
5
B
HIS
5
10.27
B
VAL
2
B
VAL
2
7
B
ASN
3
B
ASN
3
-13.00
B
GLU
21
B
GLU
21
7
B
ARG
22
B
ARG
22
-3.34
B
ARG
22
B
ARG
22
7
B
GLY
23
B
GLY
23
-1.86
B
GLY
8
B
GLY
8
8
B
SER
9
B
SER
9
-5.59
B
PRO
28
B
PRO
28
8
B
LYS
29
B
LYS
29
-10.37
A
CYS
7
A
CYS
7
9
A
THR
8
A
THR
8
-6.65
A
THR
8
A
THR
8
9
A
SER
9
A
SER
9
2.48
B
GLU
21
B
GLU
21
9
B
ARG
22
B
ARG
22
-6.74
B
DHI
24
B
DHI
24
9
B
PHE
25
B
PHE
25
-6.07
B
GLY
23
B
GLY
23
10
B
DHI
24
B
DHI
24
0.23
B
TYR
26
B
TYR
26
11
B
THR
27
B
THR
27
1.71
A
GLY
1
A
GLY
1
12
A
ILE
2
A
ILE
2
4.74
B
ASN
3
B
ASN
3
12
B
GLN
4
B
GLN
4
-0.13
B
GLY
20
B
GLY
20
12
B
GLU
21
B
GLU
21
1.04
B
PRO
28
B
PRO
28
12
B
LYS
29
B
LYS
29
-12.85
A
CYS
6
A
CYS
6
14
A
CYS
7
A
CYS
7
-7.66
B
GLY
20
B
GLY
20
14
B
GLU
21
B
GLU
21
1.46
B
PRO
28
B
PRO
28
14
B
LYS
29
B
LYS
29
3.18
A
GLY
1
A
GLY
1
15
A
ILE
2
A
ILE
2
1.50
B
CYS
19
B
CYS
19
15
B
GLY
20
B
GLY
20
9.34
A
CYS
6
A
CYS
6
16
A
CYS
7
A
CYS
7
-0.26
B
PHE
25
B
PHE
25
17
B
TYR
26
B
TYR
26
-12.67
A
VAL
3
A
VAL
3
19
A
GLU
4
A
GLU
4
-6.04
B
ASN
3
B
ASN
3
19
B
GLN
4
B
GLN
4
-1.47
B
GLN
4
B
GLN
4
19
B
HIS
5
B
HIS
5
-0.98
A
GLY
1
A
GLY
1
22
A
ILE
2
A
ILE
2
-0.78
B
CYS
7
B
CYS
7
22
B
GLY
8
B
GLY
8
-7.37
B
ASN
3
B
ASN
3
24
B
GLN
4
B
GLN
4
-8.42
B
GLY
23
B
GLY
23
24
B
DHI
24
B
DHI
24
-2.46
B
GLN
4
B
GLN
4
25
B
HIS
5
B
HIS
5
8.65
B
GLY
20
B
GLY
20
25
B
GLU
21
B
GLU
21
5.57
B
GLY
20
B
GLY
20
27
B
GLU
21
B
GLU
21
6.62
B
VAL
2
B
VAL
2
28
B
ASN
3
B
ASN
3
-5.77
A
GLN
5
A
GLN
5
29
A
CYS
6
A
CYS
6
5.36
B
CYS
19
B
CYS
19
29
B
GLY
20
B
GLY
20
-0.63
INS_HUMAN
UNP
1
90
P01308
GIVEQCCTSICSLYQLENYCN
INS_HUMAN
UNP
2
25
P01308
FVNQHLCGSHLVEALYLVCGERGFFYTPKT
90
110
2M2P
1
21
P01308
A
1
1
21
25
54
2M2P
1
30
P01308
B
2
1
30
2
PHE
ENGINEERED MUTATION
DHI
24
2M2P
B
P01308
UNP
48
24
BINDING SITE FOR RESIDUE DHI B 24
Software
4
B
TYR
16
B
TYR
16
4
1_555
B
CYS
19
B
CYS
19
4
1_555
B
GLY
23
B
GLY
23
4
1_555
B
PHE
25
B
PHE
25
4
1_555
1
P 1